Agios Pharmaceuticals, Inc.

LSE:0HB0 Stock Report

Market Cap: US$3.2b

Agios Pharmaceuticals Management

Management criteria checks 4/4

Agios Pharmaceuticals' CEO is Brian Goff, appointed in Aug 2022, has a tenure of 2.25 years. total yearly compensation is $3.42M, comprised of 23.4% salary and 76.6% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $4.39M. The average tenure of the management team and the board of directors is 2.8 years and 7.6 years respectively.

Key information

Brian Goff

Chief executive officer

US$3.4m

Total compensation

CEO salary percentage23.4%
CEO tenure2.3yrs
CEO ownership0.1%
Management average tenure2.8yrs
Board average tenure7.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brian Goff's remuneration changed compared to Agios Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$674m

Jun 30 2024n/an/a

-US$365m

Mar 31 2024n/an/a

-US$353m

Dec 31 2023US$3mUS$798k

-US$352m

Sep 30 2023n/an/a

-US$220m

Jun 30 2023n/an/a

-US$210m

Mar 31 2023n/an/a

-US$218m

Dec 31 2022US$12mUS$308k

-US$232m

Compensation vs Market: Brian's total compensation ($USD3.42M) is about average for companies of similar size in the UK market ($USD2.69M).

Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.

CEO

Brian Goff (55 yo)

2.3yrs

Tenure

US$3,416,453

Compensation

Mr. Brian M. Goff, M.B.A., is Independent Director of Intellia Therapeutics, Inc. from June 2024. He is Chief Executive Officer and Director at Agios Pharmaceuticals, Inc. from August 08, 2022. He had been...

Leadership Team

NamePositionTenureCompensationOwnership
Brian Goff
CEO & Director2.3yrsUS$3.42m0.14%
$ 4.4m
Cecilia Jones
Chief Financial Officer2.2yrsUS$1.21m0.035%
$ 1.1m
James Burns
Corporate Secretary & Chief Legal Officer2.8yrsUS$1.93m0.028%
$ 874.2k
Sarah Gheuens
Chief Medical Officer and Head of Research & Development3.2yrsUS$2.87m0.077%
$ 2.4m
Tsveta Milanova
Chief Commercial Officer1.8yrsUS$3.73m0.023%
$ 737.0k
Lewis Cantley
Founderno dataUS$333.51kno data
Tak Mak
Founderno datano datano data
Craig Thompson
Founderno datano datano data
Shin-San Su
Founderno datano datano data
T. Washburn
VP, Controller & Principal Accounting Officer3.3yrsno data0.0014%
$ 45.4k
Clive Patience
Chief Technical Operations Officer7.4yrsno datano data
Christopher J. Taylor
Vice President of Investor Relations & Corporate Communicationsno datano datano data

2.8yrs

Average Tenure

55yo

Average Age

Experienced Management: 0HB0's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Brian Goff
CEO & Director2.3yrsUS$3.42m0.14%
$ 4.4m
Jacqualyn Fouse
Chair of the Board of Directors6.9yrsUS$447.25k0.25%
$ 7.8m
Jeffrey Capello
Independent Director1.4yrsUS$663.68k0.0035%
$ 109.9k
Marc Tessier-Lavigne
Member of Scientific Advisory Board8.3yrsUS$302.85kno data
Charles Sawyers
Member of Scientific Advisory Board15.8yrsno datano data
Kaye Foster-Cheek
Lead Independent Director9.9yrsUS$440.95k0.013%
$ 420.4k
David Schenkein
Independent Director15.3yrsUS$417.25k0.83%
$ 26.5m
Joan Brugge
Member of Scientific Advisory Boardno datano datano data
Matthew Vander Heiden
Member of Scientific Advisory Board16yrsno datano data
Scott Biller
Member of Scientific Advisory Board3.8yrsUS$3.21mno data
Cynthia Smith
Independent Director2.3yrsUS$419.91k0.014%
$ 444.9k
Ralph Deberardinis
Member of Scientific Advisory Boardno datano datano data

7.6yrs

Average Tenure

64yo

Average Age

Experienced Board: 0HB0's board of directors are considered experienced (7.6 years average tenure).